Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy(Georgetown University), Rebecca B. Riggins(Georgetown University)
Cited by 1
Related Papers
Estrogen-related Receptor β (ERRβ) – Renaissance Receptor or Receptor Renaissance?
|Nuclear Receptor Signaling|2016|37
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer
|Oncotarget|2016|17
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer
|Breast Cancer Research and Treatment|2019|15
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
|Journal of the Endocrine Society|2023|11